Industry awaits FDA's policy on disclosing data in applications
This article was originally published in RAJ Devices
Executive Summary
The US Food and Drug Administration has launched the first phase of its much-vaunted transparency initiative by creating a new section on its website that offers basic information about the agency’s regulatory activities1,2.